Know Cancer

or
forgot password
  • cancer clinical trials in alaska

  • Talc in Treating Patients With Malignant Pleural Effusion
    Providence Cancer Therapy Center
    Anchorage, Alaska 99508
    Metastatic Cancer
    Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
    Providence Cancer Therapy Center
    Anchorage, Alaska 99508
    Metastatic Cancer
    SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Melanoma (Skin)
    Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
    Providence Cancer Therapy Center
    Anchorage, Alaska 99508
    Breast Cancer
    S9630, Medroxyprogesterone in Treating Women With Breast Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Breast Cancer, Endometrial Cancer
    Brachytherapy in Treating Patients With Prostate Cancer
    Providence Cancer Therapy Center
    Anchorage, Alaska 99508
    Prostate Cancer
    S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
    Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
    Fairbanks, Alaska 99701
    Adult Meningioma
    Radiation Therapy Plus Paclitaxel in Treating Patients With Nonmetastatic, Unresectable Pancreatic Cancer
    Providence Cancer Therapy Center
    Anchorage, Alaska 99508
    Pancreatic Cancer
    Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
    Providence Alaska Medical Center

    Trial Locations
    Providence Alaska Medical Center
    Alaska Regional Hospital
    Anal Cancer
    Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Gastric Cancer
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Breast Cancer
    S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Prostate Cancer
    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Myelofibrosis
    Katmai Oncology Group
    Anchorage, Alaska 99508-4627
    Chronic Myeloproliferative Disorders
    Radiation Therapy and Tamoxifen in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Brain and Central Nervous System Tumors
    Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Head and Neck Cancer, Skin Reactions Secondary to Radiation Therapy
    Chemotherapy and Radiation Therapy With or Without Fluorouracil in Treating Patients With Cancer of the Stomach Who Have Undergone Surgery
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Esophageal Cancer, Gastric Cancer
    Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Breast Cancer
    S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital
    Breast Cancer
    Iressa Expanded Access Program (EAP)
    Research Site
    Anchorage, Alaska
    Carcinoma, Non-small-cell Lung, Metastases, Neoplasm
    A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostate Cancer
    Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostatic Neoplasms
    Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostatic Neoplasms
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Anchorage Oncology Centre
    Anchorage, Alaska 99508
    Colorectal Cancer
    S0219, Combination Chemotherapy Followed By Observation or Surgery in Patients With Stage II or Stage III Cancer of the Urothelium
    Cancer Center at Providence Alaska Medical Center
    Anchorage, Alaska 99519-6604
    Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer
    YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Hormone-Refractory Prostate Cancer, Prostatic Neoplasms
    Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
    Alaska Oncology and Hematology
    Anchorage, Alaska 99508
    Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms
    Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostatic Neoplasms
    S0205 Gemcitabine w/ or w/o Cetuximab as First-Line Therapy in Locally Advanced Pancreas Cancer
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Cancer Center at Providence Alaska Medical Center
    Pancreatic Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Providence Alaska Medical Center
    Anchorage, Alaska 99508
    Lung Cancer, Non-small-cell Lung Carcinoma
    S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Esophageal Cancer
    S0508: Thalidomide and Temozolomide in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Melanoma (Skin)
    S0430 Cyclophosphamide and Capecitabine in Treating Women With Stage IV Breast Cancer
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Breast Cancer
    S0515 Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma
    Alaska Regional Hospital Cancer Center

    Trial Locations
    Alaska Regional Hospital Cancer Center
    Providence Cancer Center
    Lymphoma
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    Alaska Cancer Research & Education Center
    Anchorage, Alaska 99508
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lung Cancer
    S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
    Alaska Regional Hospital Cancer Center
    Anchorage, Alaska 99508
    Lung Cancer
    The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer
    Alaska Clinical Research Center, LLC
    Anchorage, Alaska 99508
    Prostate Cancer